Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04352270 · ClinicalTrials.gov registry record · NA

Clinic-Based Atopic Dermatitis Therapeutic Patient Education

A NA study of Atopic Dermatitis, sponsored by Boston University.

Completed
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT04352270 is a NA study of Atopic Dermatitis that has completed, run by Boston University. The registered enrollment target is 56 participants, below the 609-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04352270, a NA study of Atopic Dermatitis, has completed, sponsored by Boston University.

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this randomized trial is to determine whether comprehensive, accessible, and animation-style videos are a more effective method of therapeutic patient education (TPE) based on clinical outcomes than paper handouts in Spanish and English-speaking communities. The clinical outcomes being measured are the severity, sleep affected by atopic dermatitis (AD), and the amount of itch experienced.

Conditions Studied

Interventions

  • OTHER AD printed educational materials
  • OTHER AD educational videos

Study Locations (1)

Massachusetts

  • BMC Pediatric Dermatology Clinics - Boston

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2023-02-27
Est. Completion 2023-09-21
Phase NA

Sponsor

Boston University

185 total trials

What the Registry Record Tells You About NCT04352270

The ClinicalTrials.gov registry entry for NCT04352270 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 609-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (91% lower). The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atopic Dermatitis appearing as the primary indexed condition, and to 2 interventions - of which AD printed educational materials is the first listed.

NCT04352270 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04352270 about?

NCT04352270 is a clinical study titled "Clinic-Based Atopic Dermatitis Therapeutic Patient Education". The primary objective of this randomized trial is to determine whether comprehensive, accessible, and animation-style videos are a more effective method of therapeutic patient education (TPE) based on clinical outcomes than paper handouts in Spanish and English-speaking communities. The clinical out...

What is the current status of trial NCT04352270?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2023-02-27. Estimated completion is 2023-09-21.

What conditions does trial NCT04352270 study?

This clinical trial studies the following conditions: Atopic Dermatitis.

What interventions are being tested in trial NCT04352270?

The interventions under investigation include: AD printed educational materials (OTHER), AD educational videos (OTHER).

Who is sponsoring clinical trial NCT04352270?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04352270 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Atopic Dermatitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.